Laviceftra S 250mg/125mg Injection
Marketer
Lavish Biotech
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Laviceftra S 250mg/125mg Injection
Cefixime and Sulbactam 250mg/125mg Injection is a dual-action antibiotic. It's used to combat a range of bacterial infections by inhibiting microbial proliferation and halting infection spread. This injection requires administration by a medical professional. Strictly adhere to your prescribed dosage schedule; complete the entire course of treatment, even with symptom improvement. Premature cessation can compromise its effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening side effects to your physician immediately. Seek immediate medical attention for allergic reactions (e.g., rash, itching, swelling, respiratory distress). Inform your doctor of all current medications before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration are recommended for optimal recovery. Your doctor may order blood tests and other assessments to monitor treatment response.
Primary Ingredients of Laviceftra S 250mg/125mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Laviceftra S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Laviceftra S 250mg/125mg Injection:
Administering this medication will be done by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Laviceftra S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Laviceftra S 250mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not advised.
How Laviceftra S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Laviceftra S 250mg/125mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam, a beta-lactamase inhibitor, complements this by neutralizing enzymes that bacteria use to inactivate Ceftriaxone, thus boosting its effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Laviceftra S 250mg/125mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Laviceftra S 250mg/125mg is typically deemed safe for use during pregnancy. Preclinical trials in animals have revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
Administering Laviceftra S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The injection Laviceftra S (250mg/125mg) can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Laviceftra S 250mg/125mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Patients with severe hepatic impairment should use Laviceftra S 250mg/125mg Injection cautiously, potentially requiring dosage modification. For patients with mild to moderate liver disease, dosage alteration of Laviceftra S 250mg/125mg Injection is unnecessary; however, medical advice is always recommended.
What if you forget to take Laviceftra S 250mg/125mg Injection :
Should you forget a dose of Laviceftra S 250mg/125mg Injection, seek medical advice.
Facts to Know About Laviceftra S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
3,018 People bought this recently